Core Insights - Bon Natural Life Limited has developed a patent-pending Glucoraphanin-Myrosinase co-delivery system that enhances the bio-activity of glucoraphanin, a key compound in broccoli [1][3] - Sulforaphane, derived from glucoraphanin, is linked to various health benefits including anti-cancer properties, neuroprotection, and digestive health [2][3] - The new technology aims to improve the conversion efficiency of glucoraphanin to sulforaphane, addressing the bio-availability issue and unlocking significant market potential in functional foods and beverages [3][4] Company Overview - Bon Natural Life Limited operates in the natural, health, and personal care industries, focusing on bio-ingredient solutions [1][4] - The company is scheduled to enter the market with its new technology in Q2 2025, which is expected to broaden the broccoli-derived wellness market [4] Market Potential - The advancements in sulforaphane applications are projected to create a multi-billion-dollar market opportunity across various sectors, particularly in anti-tumor therapies and mental health support [3]

XI’AN, China, April 08, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation addresses nutritional critical challenges through a patent-pending Glucoraphanin-Myrosinase co-delivery system that significantly enhances the bio-activity of glucoraph anin, a key bio-active compound in broccoli. Broccoli stands as a nutrient-rich super food containing ...

Company Overview - Bon Natural Life Limited (NASDAQ:BON) is a leading bio-ingredient solution provider in the natural, health, and personal care industry [1] - The company is based in the Cayman Islands and focuses on innovative formulations in the health sector [4] Recent Developments - From October 2024 to January 2025, the company achieved significant advancements in bio-manufacturing technology for tea pigments, reaching an industrial-leading yield rate of 12-16% while maintaining purity levels above 95% [1] - The company plans to pursue innovative tea pigment-based products aimed at gastrointestinal and metabolic health through strategic partnerships [3] Industry Insights - Tea pigments demonstrate significant biological properties, including lipid-lowering, blood glucose reduction, antioxidant effects, and anti-peptic ulcer benefits, indicating broad applicability across various health sectors [2] - The global tea pigment industry is projected to exceed $12 billion by 2025, highlighting the potential for innovative applications in the market [2]

BONDUELLE Head office: "La Woestyne" - 59173 Renescure - France Bonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 euros Registered under number : 447 250 044 ( Dunkerque Commercial and Companies Register) Press Release Villeneuve d'Ascq, April 1, 2025 Sale of our packaged salad business in Germany Our 4 flagship brands are Bonduelle, Ready Pac Foods, Cassegrain, Globus. Bonduelle is listed on Euronext Paris compartment B Euronext indices: CAC MID & SMALL – CAC FOOD PRO ...

XI'AN, China, March 20, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced a game-changing patent for a natural postbiotic ingredient designed to regulate blood sugar is gearing up for release. The Company has engineered a food-derived postbiotic formula for glycemic management, slated to hit shelves in the near term. When taken 10-30 minutes before meals, this breakt ...

Core Viewpoint - Univest Securities, LLC has successfully closed a Best Efforts Offering for Bon Natural Life Limited, a prominent provider of bio-ingredient solutions in the natural health and personal care sectors, raising approximately $12 million in gross proceeds [1][4]. Group 1: Offering Details - The offering consisted of 8,333,332 shares of Class A ordinary shares and included Series A and Series B Warrants with exercise prices of $1.44 and $2.16 per share, respectively [2]. - Each ordinary unit was priced at $1.44, while pre-funded units were priced at $1.439 [3]. - The Warrants are immediately exercisable upon issuance and will expire three years after their initial exercise date [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated towards sales network expansion, research and development, production capacity expansion, and general corporate purposes [4]. Group 3: Company Information - Bon Natural Life Limited is based in the Cayman Islands and operates within the natural health and personal care industries [8]. - Univest Securities, LLC, established in 1994, provides a range of financial services including investment banking and advisory, and acts as the sole placement agent for this offering [7].

Core Insights - The materials sector has several oversold stocks, presenting potential buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, typically below 30 [1] Company Summaries - **Bon Natural Life Ltd (BON)**: Recently announced a $12 million offering of 8,333,332 shares at $1.44/share. The stock has fallen approximately 53% over the past month, with a 52-week low of $0.55. Current RSI is 29.5, and shares closed at $0.61 after a 57.5% dip [3] - **ZK International Group Co Ltd (ZKIN)**: Resolved Nasdaq bid price deficiency and remains compliant. The stock has decreased around 27% in the last month, with a 52-week low of $1.24. Current RSI is 28, and shares closed at $1.30 [3] - **Perimeter Solutions Inc (PRM)**: Reported positive quarterly results but saw a stock decline of about 24% over the past month, with a 52-week low of $6.01. Current RSI is 29.8, and shares closed at $9.09 after a 1.4% drop [3]

Core Viewpoint - Bon Natural Life Limited has announced a best efforts offering of units for aggregate gross proceeds of $12 million, aimed at expanding its operations in the natural, health, and personal care industries [1][3]. Offering Details - The offering consists of 8,333,332 shares of Class A ordinary shares and associated Series A and Series B Warrants, with exercise prices of $1.44 and $2.16 per share respectively [2]. - The purchase price for each ordinary unit is set at $1.44, while pre-funded units will be priced at $1.439 [3]. - The offering is expected to close around March 18, 2025, pending customary closing conditions [3]. Use of Proceeds - The net proceeds from the offering will be utilized for sales network expansion, research and development, production capacity expansion, and general corporate purposes [3]. Placement Agent - Univest Securities, LLC is acting as the sole placement agent for this offering [4]. Company Background - Bon Natural Life Limited is a Cayman Islands company focused on providing bio-ingredient solutions in the natural, health, and personal care sectors [6].

Core Points - The company Bonduelle has released its Half Year Financial Report for the period ending December 31, 2024 [3] - The report has been filed with the AMF and is accessible on the company's official website [3][4] - Bonduelle is a French S.C.A with a registered capital of 57,102,699.50 euros [2]

Core Insights - The Bonduelle Group reported a strong growth of +17.8% in current operating income for the first half of the 2024-2025 fiscal year, amounting to 48 million euros, compared to 40.6 million euros in the previous fiscal year [4][22] - Despite a slight decline in overall sales, branded activities showed a growth of +1.9%, highlighting the strategic importance of brand development [6][10] - The company confirmed its annual objectives despite challenges such as poor agricultural harvests in Russia impacting profitability in the second half of the fiscal year [7][38] Financial Performance - Total sales for the first half of fiscal year 2024-2025 were 1,119.4 million euros, a decrease of -1.7% compared to 1,139.2 million euros in the previous fiscal year [5][15] - The current operating margin improved to 4.3%, up from 3.6% in the previous year, reflecting operational efficiency [14][22] - Net income from continuing operations increased significantly to 17.2 million euros, compared to 6.4 million euros in the previous fiscal year, representing 1.5% of sales [29] Sales Breakdown - Sales in the Europe Zone decreased by -5.6% on reported figures, primarily due to a decline in private label canned activities [16][18] - The Non-Europe Zone experienced growth of +4.8% on reported figures, with North America returning to growth for the first time in four years [20][24] - The canned segment saw a decline of -6.7%, while fresh processed activities grew by +4.7% [17] Strategic Initiatives - The "Transform to win" transformation plan is underway, focusing on brand development and operational excellence [9][10] - The company is working towards achieving a 100% B Corp group certification by the end of the year, emphasizing its commitment to sustainability [10] - Plans to sell the packaged salad activity in France and Germany are in progress, with agreements reached regarding employee support during the transition [35][36] Financial Situation - Net financial debt stood at 664 million euros as of December 31, 2024, an increase from 649 million euros the previous year [33] - The gearing ratio increased to 1.23 from 0.95, indicating a higher level of financial leverage [33] - The average financing rate decreased to 4.12%, reflecting improved debt management [27]